Mami Ojima - Concepedia

Author

Mami Ojima

Takeda (Japan)

Also Known As

Mami OJIMA, Mami Ojima

Publications

541

Citations

H-Index

Concepts

All Affiliations

Takeda (Japan)

About

Mami Ojima is an author at Takeda (Japan) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	361
2	Natural Sciences	1	1	125
3	Biochemistry	1	1	125
4	Diabetes	1	1	53
5	Endocrinology	1	1	29

Mami Ojima

Publications

538

Citations

H-Index

Page 1

	Year	Citations
In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies Mami Ojima, Hideki Igata, Masayuki Tanaka, Journal of Pharmacology and Experimental Therapeutics	2010	146
Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor Mami Ojima, Yoshiyuki Inada, Yumiko Shibouta, European Journal of Pharmacology Molecular PharmacologyAngiotensin At1 ReceptorMolecular PhysiologyMedicineVascular Pharmacology	1997	141
Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles Keiji Kubo, Yoshiyuki Inada, Yasuhisa Kohara, Journal of Medicinal Chemistry Biological ActivityMolecular PharmacologyMedicinal ChemistryAngiotensin IiBenzimidazole Ring	1993	125
Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models Keiji Kusumoto, Hideki Igata, Mami Ojima, European Journal of Pharmacology HypertensionMedicineAntihypertensive TherapyPhysiologyDiabetes	2011	53
Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone Takeo Wada, Yoshiyuki Inada, Tsukasa Sanada, European Journal of Pharmacology Molecular PharmacologyHypertensionMedicineAntihypertensive TherapyPhysiology	1994	29
Combined Effects of the Angiotensin II Antagonist Candesartan Cilexetil(TCV-116) and Other Classes of Antihypertensive Drugs in Spontaneously Hypertensive Rats. Takeo Wada, Tsukasa Sanada, Mami Ojima, Hypertension Research	1996	16
Comparison of the Antihypertensive Effects of the New Angiotensin II(AT1) Receptor Antagonist Candesartan Cilexetil(TCV-116) and the Angiotensin Converting Enzyme Inhibitor Enalapril in Rats. Takeo Wada, Yoshiyuki Inada, Mami Ojima, Hypertension Research	1996	15
Regional Hemodynamic Effects of Candesartan Cilexetil (TCV-116), an Angiotensin II AT1-Receptor Antagonist, in Conscious Spontaneously Hypertensive Rats. Ray Kanagawa, Takeo Wada, Tsukasa Sanada, The Japanese Journal of Pharmacology Molecular PharmacologyHypertensionCardiovascular DiseaseCandesartan CilexetilMedicine	1997	13

Page 1